{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:45:09Z","timestamp":1758635109062},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2002,5,1]]},"DOI":"10.1038\/sj.leu.2402471","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:32:24Z","timestamp":1031164344000},"page":"861-864","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Phenotypic transformation of CD52pos to CD52neg leukemic T cells as a mechanism for resistance to CAMPATH-1H"],"prefix":"10.1038","volume":"16","author":[{"given":"RE","family":"Birhiray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Guldan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Rudolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Delmastro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Santabarbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Brettman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,5,2]]},"reference":[{"key":"BF2402471_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1042\/bj2930633","volume":"293","author":"MQ Xia","year":"1993","unstructured":"Xia MQ, Hale G, Lifely MR, Ferguson MA, Campbell D, Packman L, Waldmann H . Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis Biochem J 1993 293: 633\u2013640","journal-title":"Biochem J"},{"key":"BF2402471_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1399-0039.1990.tb01767.x","volume":"35","author":"G Hale","year":"1990","unstructured":"Hale G, Xia MQ, Tighe HP, Dyer MJ, Waldmann H . The CAMPATH-1 antigen (CDw52) Tiss Antigen 1990 35: 118\u2013127","journal-title":"Tiss Antigen"},{"key":"BF2402471_CR3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood.V82.3.807.807","volume":"82","author":"MH Gilleece","year":"1993","unstructured":"Gilleece MH, Dexter TM . Effect of Campath-1H antibody on human hematopoietic progenitors in vitro Blood 1993 82: 807\u2013812","journal-title":"Blood"},{"key":"BF2402471_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/10428199009053522","volume":"2","author":"MJ Dyer","year":"1990","unstructured":"Dyer MJ, Hale G, Marcus R, Waldmann H . Remission induction in patients with lymphoid malignancies using unconjugated CAMPATH-1 monoclonal antibodies Leuk Lymph 1990 2: 179\u2013193","journal-title":"Leuk Lymph"},{"key":"BF2402471_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0145-2126(97)00158-6","volume":"22","author":"L Ginaldi","year":"1998","unstructured":"Ginaldi L, DeMartinis M, Matutes E, Farahat N, Morilla R, Dyer MJ, Catovsky D . Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H Leuk Res 1998 22: 185\u2013191","journal-title":"Leuk Res"},{"key":"BF2402471_CR6","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V73.6.1431.1431","volume":"73","author":"MJ Dyer","year":"1989","unstructured":"Dyer MJ, Hale G, Hayhoe FG, Waldmann H . Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype Blood 1989 73: 1431\u20131439","journal-title":"Blood"},{"key":"BF2402471_CR7","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/0140-6736(92)92294-P","volume":"340","author":"JD Isaacs","year":"1992","unstructured":"Isaacs JD, Watts RA, Hazleman BL, Hale G, Keogan MT, Cobbold SP, Waldmann H . Humanised monoclonal antibody therapy for rheumatoid arthritis Lancet 1992 340: 748\u2013752","journal-title":"Lancet"},{"key":"BF2402471_CR8","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/eji.1830181006","volume":"18","author":"CI Bindon","year":"1988","unstructured":"Bindon CI, Hale G, Waldmann H . Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies Eur J Immunol 1988 18: 1507\u20131514","journal-title":"Eur J Immunol"},{"key":"BF2402471_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/332323a0","volume":"332","author":"L Riechmann","year":"1988","unstructured":"Riechmann L, Clark M, Waldmann H, Winter G . Reshaping human antibodies for therapy Nature 1988 332: 323\u2013327","journal-title":"Nature"},{"key":"BF2402471_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2249.1992.tb06421.x","volume":"87","author":"JS Crowe","year":"1992","unstructured":"Crowe JS, Hall VS, Smith MA, Cooper HJ, Tite JP . Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material Clin Exp Immunol 1992 87: 105\u2013110","journal-title":"Clin Exp Immunol"},{"key":"BF2402471_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/bjo.84.1.107","volume":"84","author":"AD Dick","year":"2000","unstructured":"Dick AD, Meyer P, James T, Forrester JV, Hale G, Waldmann H, Isaacs JD . Campath-1H therapy in refractory ocular inflammatory disease Br J Ophthalmol 2000 84: 107\u2013109","journal-title":"Br J Ophthalmol"},{"key":"BF2402471_CR12","first-page":"2208","volume":"94","author":"RE Curtis","year":"1999","unstructured":"Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF Jr, Deeg HJ . Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study Blood 1999 94: 2208\u20132216","journal-title":"Blood"},{"key":"BF2402471_CR13","first-page":"52","volume":"26","author":"MJ Dyer","year":"1999","unstructured":"Dyer MJ . The role of CAMPATH-1 antibodies in the treatment of lymphoid malignancies Semin Oncol 1999 26: 52\u201357","journal-title":"Semin Oncol"},{"key":"BF2402471_CR14","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1046\/j.1365-2141.2000.01879.x","volume":"108","author":"GM Cull","year":"2000","unstructured":"Cull GM, Haynes AP, Byrne JL, Carter GI, Miflin G, Rebello P, Hale G, Waldmann H, Russell NH . Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity Br J Haematol 2000 108: 754\u2013760","journal-title":"Br J Haematol"},{"key":"BF2402471_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/107327489800500102","volume":"5","author":"E Matutes","year":"1998","unstructured":"Matutes E . T-cell prolymphocytic leukemia Cancer Control 1998 5: 19\u201324","journal-title":"Cancer Control"},{"key":"BF2402471_CR16","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1200\/JCO.1997.15.7.2667","volume":"15","author":"R Pawson","year":"1997","unstructured":"Pawson R, Dyer MJ, Barge R, Matutes E, Thornton PD, Emmett E, Kluin-Nelemans JC, Fibbe WE, Willemze R, Catovsky D . Treatment of T-cell prolymphocytic leukemia with human CD52 antibody J Clin Oncol 1997 15: 2667\u20132672","journal-title":"J Clin Oncol"},{"key":"BF2402471_CR17","first-page":"S103","volume":"38 (Suppl. 2)","author":"D Catovsky","year":"1996","unstructured":"Catovsky D . Clinical experience with 2\u2032-deoxycoformycin Hematol Cell Ther 1996 38 (Suppl. 2): S103\u2013S107","journal-title":"Hematol Cell Ther"},{"key":"BF2402471_CR18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood.V86.4.1487.bloodjournal8641487","volume":"86","author":"B Hertenstein","year":"1995","unstructured":"Hertenstein B, Wagner B, Bunjes D, Duncker C, Raghavachar A, Arnold R, Heimpel H, Schrezenmeier H . Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma Blood 1995 86: 1487\u20131492","journal-title":"Blood"},{"key":"BF2402471_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/intimm\/8.3.325","volume":"8","author":"SJ Brett","year":"1996","unstructured":"Brett SJ, Baxter G, Cooper H, Rowan W, Regan T, Tite J, Rapson N . Emergence of CD52-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment Int Immunol 1996 8: 325\u2013334","journal-title":"Int Immunol"},{"key":"BF2402471_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/(SICI)1097-0320(19971015)30:5<249::AID-CYTO6>3.0.CO;2-C","volume":"30","author":"BH Davis","year":"1997","unstructured":"Davis BH, Foucar K, Szczarkowski W, Ball E, Witzig T, Foon KA, Wells D, Kotylo P, Johnson R, Hanson C, Bessman D . US\u2013Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications Cytometry 1997 30: 249\u2013263","journal-title":"Cytometry"},{"key":"BF2402471_CR21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC . A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84: 1361\u20131392","journal-title":"Blood"},{"key":"BF2402471_CR22","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1042\/bj3220919","volume":"322","author":"VC Taylor","year":"1997","unstructured":"Taylor VC, Sims M, Brett S, Field MC . Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism Biochem J 1997 322: 919\u2013925","journal-title":"Biochem J"},{"key":"BF2402471_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-2567.1998.00615.x","volume":"95","author":"W Rowan","year":"1998","unstructured":"Rowan W, Tite J, Topley P, Brett SJ . Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells Immunology 1998 95: 427\u2013436","journal-title":"Immunology"},{"key":"BF2402471_CR24","first-page":"611","volume":"5","author":"TA Davis","year":"1999","unstructured":"Davis TA, Czerwinski DK, Levy R . Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression Clin Cancer Res 1999 5: 611\u2013615","journal-title":"Clin Cancer Res"},{"key":"BF2402471_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/4772","volume":"5","author":"M Hellerstein","year":"1999","unstructured":"Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Deeks S, McCune JM . Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans Nature Med 1999 5: 83\u201389","journal-title":"Nature Med"},{"key":"BF2402471_CR26","first-page":"209","volume":"12","author":"D Bunjes","year":"1993","unstructured":"Bunjes D, Theobald M, Wiesneth M, Schrezenmeier H, Hoffmann T, Hertenstein B, Arnold R, Heimpel H . Graft rejection by a population of primed CDw52-host T cells after in vivo\/ex vivo T-depleted bone marrow transplantation Bone Marrow Transplant 1993 12: 209\u2013215","journal-title":"Bone Marrow Transplant"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402471.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402471","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402471.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:13:40Z","timestamp":1648764820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,1]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5,1]]}},"alternative-id":["BF2402471"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402471","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5,1]]},"assertion":[{"value":"4 May 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}